Lee Joon-sung, the new chairman of the Korean Association for the Study of Hepatocellular Cancer, will be revised
Jun 30, 2025
Professor Lee Joon-sung (International Medicine) of Ilsan Paik Hospital at Inje University was inaugurated as the 27th president of the Korean Liver Cancer Society at the regular general meeting of the Korean Liver Cancer Society in 2025. The term of office is one year from July 2025 to June 2026.
Chairman Lee Jun-sung majored in gastroenterology and has conducted many clinical experiences and studies in the fields of liver cancer, hepatitis and cirrhosis.
Chairman Lee Jun-sung said, `For the past 26 years, the Korean Association of Liver Diseases has carried out various academic activities such as multidisciplinary cooperation and research, promoting internationalization of academic journals, establishing large-scale data on liver cancer patients in Korea, public relations and education on liver cancer, and supporting research funds with leading overseas liver cancer societies"In this 27th term, we will further promote multidisciplinary discussions and research sharing that are practically helpful in the field of care, and revise the guidelines for hepatocellular carcinoma treatment that reflect the latest findings of liver cancer research." he said.
In addition, we will resume educational programs, including liver cancer schools, which were suspended due to the suspension of " and actively discover and support young liver cancer researchers in the future through research support for young researchers. In addition, we will do our best to reorganize the rules of the society to become a more substantial society and to allow the society's face, 'Journal of River Cancer', to enter the international academic journal," he stressed,
Meanwhile, the Korean Liver Cancer Society was founded in 1999 and celebrated its 26th anniversary this year. It is a multidisciplinary academic organization with experts from internal medicine, surgery, radiology, pathology, and radiation oncology for the purpose of improving liver cancer-related treatment and research, and currently has about 870 members.
Chairman Lee Jun-sung majored in gastroenterology and has conducted many clinical experiences and studies in the fields of liver cancer, hepatitis and cirrhosis.
Chairman Lee Jun-sung said, `For the past 26 years, the Korean Association of Liver Diseases has carried out various academic activities such as multidisciplinary cooperation and research, promoting internationalization of academic journals, establishing large-scale data on liver cancer patients in Korea, public relations and education on liver cancer, and supporting research funds with leading overseas liver cancer societies"In this 27th term, we will further promote multidisciplinary discussions and research sharing that are practically helpful in the field of care, and revise the guidelines for hepatocellular carcinoma treatment that reflect the latest findings of liver cancer research." he said.
In addition, we will resume educational programs, including liver cancer schools, which were suspended due to the suspension of " and actively discover and support young liver cancer researchers in the future through research support for young researchers. In addition, we will do our best to reorganize the rules of the society to become a more substantial society and to allow the society's face, 'Journal of River Cancer', to enter the international academic journal," he stressed,
Meanwhile, the Korean Liver Cancer Society was founded in 1999 and celebrated its 26th anniversary this year. It is a multidisciplinary academic organization with experts from internal medicine, surgery, radiology, pathology, and radiation oncology for the purpose of improving liver cancer-related treatment and research, and currently has about 870 members.
|
This article was translated by Naver AI translator.
